Clinical Trials on Psychotic Disorder Not Otherwise Specified (NOS)

Total 6431 results

University of Arizona
Institute for Mental Health Research

Completed

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

Schizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS) | Recent-Onset Psychosis

United States
Nathan Kline Institute for Psychiatric Research
Stanley Medical Research Institute

Completed

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Autism Spectrum Disorder | Bipolar I Disorder | Psychotic Disorder Not Otherwise Specified | Bipolar II | Bipolar NOS(Not Otherwise Specified)

United States
Northwell Health

Withdrawn

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform | Psychosis Not Otherwise Specified (NOS)

United States
Pakistan Institute of Living and Learning
Stanley Medical Research Institute; Dow University of Health Sciences; Abbasi... and other collaborators

Completed

Randomized Double Blind Placebo Control Study in Patients With Schizophrenia (ROSES)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis Not Otherwise Specified

Pakistan
Pakistan Institute of Living and Learning
Dow University of Health Sciences; Karwan e Hayat

Completed

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis Not Otherwise Specified

Pakistan
University of Arizona

Terminated

Social Cognition in Longstanding Psychosis

Schizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Psychosis Not Otherwise Specified (NOS) | Bipolar Disorder With Psychotic Features

United States
University of North Carolina, Chapel Hill

Completed

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study (SATIETY)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Autism Spectrum Disorder | Major Depressive Disorder | Prodromal Schizophrenia | Mood Disorder | Psychotic Disorder, Not Otherwise Specified | Depressive Disorder, Not Otherwise Specified | Mood Disorder, Not Otherwise...

United States
Northwell Health
National Alliance for Research on Schizophrenia and Depression; The Zucker...

Terminated

Optimizing Response in Psychosis Study (ORP)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder Not Otherwise Specified

United States
University of Arizona

Completed

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

Schizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS)

United States
Chonbuk National University Hospital

Completed

Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder Not Otherwise Specified | Schizophreniform Disorders | Schizophrenia Spectrum Disorders

Korea, Republic of
AstraZeneca
acromion GmbH

Terminated

Schizophrenic Patients Taking Part in Integrated Care Program (CARE I)

Schizophrenia | Schizoaffective Disorder | Delusional Disorder | Psychotic Disorder Not Otherwise Specified | Schizophreni-form Disorder

Germany
Northwell Health

Completed

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder Not Otherwise Specified | Severe Bipolar Disorder With Psychotic Features

United States
New York State Psychiatric Institute

Withdrawn

A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults

Major Depressive Disorder | Dysthymic Disorder | Depressive Disorder Not Otherwise Specified (NOS)

United States
University of Minnesota
Ontario Mental Health Foundation

Completed

Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders

Depression | Bipolar Disorder | Bipolar Disorder Not Otherwise Specified | Unspecified Mood Disorder

United States
University of Minnesota
University of California, San Francisco

Completed

Minnesota Community-Based Cognitive Training in Early Psychosis (Mini-COTES)

Schizophrenia | Schizoaffective Disorder | Psychosis | Psychosis NOS | Schizophreniform Disorders | Unspecified Psychosis | Bipolar Disorder With Psychotic Features | Depression Psychotic Feature

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified

United States
Wake Forest University Health Sciences
National Institute of Mental Health (NIMH)

Completed

Treatment of Late-life Anxiety in Primary Care Settings

Generalized Anxiety Disorder | Panic Disorder | Anxiety Disorder Not Otherwise Specified
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditions

United States
University of Minnesota
National Institute of Mental Health (NIMH)

Recruiting

EPI-MINN: Targeting Cognition and Motivation - National

Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Schizo Affective Disorder | Prodromal Schizophrenia | Major Depression With Psychotic Features | Schizophreniform Disorders | Unspecified Psychosis | Psychosis Nos/Other

United States
Forest Laboratories

Completed

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Autistic Disorder | Autism | Autism Spectrum Disorders | Asperger Syndrome | Asperger's Disorder | Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, France, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine
New York State Psychiatric Institute

Completed

Dichotic Listening as a Predictor of Medication Response in Depression

Major Depression | Dysthymia | Depressive Disorder Not Otherwise Specified

United States
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Completed

Prevention of Weight Gain in Early Psychoses

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Major Depressive Disorder | Bipolar I Disorder | Bipolar II Disorder | Psychosis Not Otherwise Specified | Substance-Induced Psychoses

Canada
Forest Laboratories

Completed

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine, Australia, Canada, France, Singapore
Wake Forest University Health Sciences
Atrium Health Levine Cancer Institute

Recruiting

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Leukemia, Not Otherwise Specified | Leukemia, Other

United States
Forest Laboratories

Terminated

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Estonia, Hungary, Iceland, Italy, Korea, Republic of, Serbia, Ukraine, Canada, Colombia, Belgium, France, New Zealand, Poland, South Africa, Spain
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma

United States
Hospital Clinic of Barcelona
University of California, San Diego

Unknown

Cognitive Behavioral Social Skills Training in Early Onset Psychosis

Schizophrenia | Schizoaffective Disorder | Psychosis NOS

Spain
Oslo University Hospital
South-Eastern Norway Regional Health Authority; Stiftelsen Helse og Rehabilitering

Unknown

Cognitive Remediation in Early Phase Psychosis

Schizophrenia | Schizoaffective Disorder | Psychosis NOS

Norway
M.D. Anderson Cancer Center

Active, not recruiting

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditions

United States
New York State Psychiatric Institute

Completed

A Study of L-DOPA for Depression and Slowing in Older Adults

Major Depressive Disorder | Dysthymia | Depression Not Otherwise Specified | Decreased Processing Speed | Decreased Gait Speed

United States
Virginia Commonwealth University

Terminated

Efficacy of a Patient Education Video

Malignant Neoplasm | Leukemia, Not Otherwise Specified

United States
Iris Sommer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ziekenhuis... and other collaborators

Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (RAPSODI)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Rhode Island Hospital

Recruiting

A Treatment Engagement Protocol for Psychiatrically Hospitalized Adolescents at Clinical High Risk for Psychosis

Psychosis Nos/Other

United States
Brown University
National Institute of Mental Health (NIMH)

Completed

Psychosis Screening in Juvenile Justice (JJ-Psychosis)

Psychotic Disorders | Psychosis Nos/Other

United States
Centre for Addiction and Mental Health

Completed

RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting

Schizophrenia | Psychosis | Psychosis NOS

Canada
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
Columbia Northwest Pharmaceuticals

Completed

Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms

Major Depressive Disorder | Borderline Personality Disorder | Dysthymia | Depression Not Otherwise Specified

United States
Sanofi

Completed

A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen (Grano-Tax)

Neoplasms (no Otherwise Specified)

South Africa
University of Washington
Genentech, Inc.

Suspended

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich... and other conditions

United States
Northwell Health
Boston University; University of Pittsburgh; Dartmouth-Hitchcock Medical Center

Completed

Improving Care and Reducing Cost Study (ICRC)

Schizophrenia | Schizoaffective Disorder | Psychosis NOS

United States
Mental Health Services in the Capital Region, Denmark

Recruiting

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis (OPUS-YOUNG)

Schizophrenia | Schizoaffective Disorder | Delusional Disorder | Depression Severe | Schizotypal Disorder | Acute and Transient Psychotic Disorder, Unspecified | Non-Organic Psychosis | Substance Induced Psychoses

Denmark
Towson University
Duke University; University of the Sciences in Philadelphia

Completed

Family Treatment for Adolescents With Anorexia Nervosa

Anorexia Nervosa | Subthreshold Anorexia Nervosa | Eating Disorder Not Otherwise Specified, Primarily Restriction

United States
Duke University

Completed

Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa (ASFT)

Anorexia Nervosa | Subthreshold Anorexia Nervosa | Eating Disorder Not Otherwise Specified, Primary Restriction

United States
Northwell Health
University of Maryland, Baltimore; Centre for Addiction and Mental Health; Wellcome...

Recruiting

iTBS to Enhance Social Cognition in People With Psychosis (iSCIP)

Schizophrenia | Schizo Affective Disorder | Schizophreniform Disorders | Psychosis Nos/Other

United States
University of Minnesota
National Institute of Mental Health (NIMH)

Recruiting

Remote State Representation in Early Psychosis (Rem-STEP)

Psychotic Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Psychosis | Schizo Affective Disorder | Schizophreniform Disorders | Psychoses, Affective | Psychotic Mood Disorders | Psychosis Nos/Other

United States
Mclean Hospital
National Institute of Mental Health (NIMH); Massachusetts General Hospital; Boston... and other collaborators

Recruiting

Enhanced Coordinated Specialty Care for Early Psychosis

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Psychosis Nos/Other

United States
New York State Psychiatric Institute
Columbia University

Completed

Interpersonal Psychotherapy for Depressed Adolescents and Parents

Major Depression | Adjustment Disorders | Dysthymic Disorder | Depressive Disorder Not Otherwise Specified
Iris Sommer
Stanley Medical Research Institute

Completed

Simvastatin Addition for Patients With Recent-onset Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Mae Lynn Reyes-Rodriguez, PhD
National Institute of Mental Health (NIMH); University of North Carolina, Chapel... and other collaborators

Completed

Engaging Latino Families in Eating Disorders Treatment (PAS)

Bulimia Nervosa | Binge Eating Disorder | Eating Disorder Not Otherwise Specified

United States
Northwestern University
National Cancer Institute (NCI)

Recruiting

Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditions

United States

Clinical Trials on Psychotic Disorder Not Otherwise Specified (NOS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations